New insider activity at Universal Health ( (UHS) ) has taken place on October 30, 2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Director Elliot Mba Sussman has recently sold 965 shares of Universal Health stock, amounting to a total value of $217,790.
Recent Updates on UHS stock
Universal Health Services (UHS) reported a strong Q3 2025 performance with a significant increase in net income to $373 million and a 13.4% rise in net revenues, leading to an upward revision of its full-year forecast. The company’s earnings call highlighted a 53% increase in EPS, driven by strategic hospital openings and a $90 million benefit from the D.C. Medicaid program. However, increased liability reserves and legal settlements posed challenges. Analysts have adjusted price targets based on these developments, with Wells Fargo raising its target due to strong financial health and strategic advancements, while Barclays lowered its target citing potential pressures from new regulatory implementations. UHS’s focus on expanding its healthcare infrastructure and enhancing operational efficiencies positions it for continued growth, despite modest growth in the behavioral health segment and pending Medicaid approvals in Florida and Nevada.
Spark’s Take on UHS Stock
According to Spark, TipRanks’ AI Analyst, UHS is a Outperform.
Universal Health Services demonstrates strong financial performance and positive earnings call outcomes, driving a high overall score. The technical analysis suggests bullish momentum, though caution is advised due to overbought signals. Valuation is reasonable, but the low dividend yield may deter some investors.
To see Spark’s full report on UHS stock, click here.
More about Universal Health
YTD Price Performance: 25.99%
Average Trading Volume: 704,417
Technical Sentiment Signal: Buy
Current Market Cap: $14.33B